The PHOENIX™ mission is to provide health care professionals
with a comprehensive continuing medical education program focused on
evolving concepts in the management of hepatitis C treatment failures
that results in improved patient care.
CME/CE/CPE INFORMATION
This educational activity is sponsored by The France Foundation and is
supported by an educational grant from InterMune.
Educational Need
Hepatitis C virus (HCV) is the most common chronic blood-borne infection
in the United States, affecting an estimated four million Americans
with an additional 35,000 new cases developing annually. HCV varies
greatly in its clinical course and outcome. If undetected or untreated,
HCV infection can lead to chronic disease, including liver fibrosis,
cirrhosis, and liver cancer.
An alarming 50% of HCV patients fail the currently accepted standard
of care, combination therapy with pegylated interferon and ribavirin.
Due to the overall prevalence of HCV and the high percentage of treatment
failures, increased education and ongoing research is needed to provide
further insights regarding the scientific basis for treatment failures,
and exploring therapeutic strategies aimed at optimizing outcomes in
patients who fail to respond to first-line therapy.
This educational activity is designed to provide physicians and other
health care providers treating patients with HCV with the tools necessary
to recognize and utilize different options when managing treatment
failures.
Intended Audience
This educational activity is intended for hepatologists, gastroenterologists,
and other health care professionals managing patients with HCV.
Learning Objectives
After reviewing the information included, participants will be able
to:
- Explain the hepatitis C virus infection and the consequences of
treatment failure
Describe the underlying scientific basis for HCV
treatment failure
Utilize knowledge learned concerning therapeutic
options for patients who fail initial HCV treatment to improve
the management of treatment
failures
Apply knowledge gained to enhance outcomes for HCV infected
patients experiencing treatment failure
Accreditation/Designation of Credit Statements
CME Statement
The France Foundation is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education
for physicians.
The France Foundation designates this educational activity for a maximum
of 4.0 category 1 credits toward the AMA Physician's Recognition Award.
Each participant should claim only those credits that he/she actually
spent in the educational activity.
Release Date: June 1, 2005
Expiration Date: June 1, 2006
CE Statement
 This
program has been approved for 4.0 contact hours of continuing education
by the American Academy of Nurse Practitioners. Program ID 0502075.
Release Date: June 1, 2005
Expiration Date: June 1, 2006
CPE Statement
 The France Foundation is accredited by the Accreditation Council for
Pharmacy Education as a provider of continuing pharmacy education.
The program number is 391-000-05-002-H04. To receive the 4.0 contact
hours of continuing education credit, pharmacists must complete the
entire program and all evaluations at its conclusion.
Release Date: June 1, 2005
Expiration Date: June 1, 2006
Statement on Conflicts of Interest
Faculty of continuing medical education programs sponsored by The France
Foundation are expected to disclose any real or perceived conflict
of interest related to the content of their presentations. Faculty
disclosures are included. Click here for full details.
Disclaimer
The France Foundation presents this activity for educational purposes
only. Participants are expected to utilize their own expertise and
judgment while engaged in the practice of medicine. The content of
the activity is provided solely by faculty who have been recognized
for expertise in their field.
Method of Participation
This activity, which consists of slides in PowerPoint® format with
speaker notes, interactive case studies and patient education tools,
should take approximately 4.0 hours to complete. The participant should,
in the order listed below:
- Read the objectives and other introductory information herein
Review the slides, case studies, and patient education
tools
Record your answers on the CME/CE/CPE Posttest
Complete the CME/CE/CPE Registration/Evaluation form
Participants who complete the Posttest and Registration/Evaluation
form will be issued a CME/CE/CPE certificate within 4 to 6 weeks
of submission of both forms to The France Foundation. Instructions
for
submission are found on the CME/CE/CPE Registration/Evaluation
form.
The evaluation form provides each participant with the opportunity
to comment on the quality of the instructional process, the perception
of enhanced professional effectiveness, the perception of commercial
bias, and his or her views on future educational needs. To receive
credit for this activity, follow the instructions provided on the
posttest. This credit will be valid through June 2006. No credit
will be given
after this date.
Click here to open the CME Posttest and Registration/Evaluation Form.
The form is offered in Adobe® Acrobat® (PDF) format. If needed,
you can acquire the free software here » download
Acrobat Reader®.
Contact Information
For further information or additional copies, please contact:
The France Foundation
Attn: PHOENIX Secretariat
230 Shore Road, Suite 202
Old Lyme, Connecticut 06371
Toll free: 1-866-227-6411
Fax: 1-866-227-6412
E-mail:info@phoenixcme.org
|
